SCHEMBL97371

SCHEMBL97371

COc1ccccc1OC=O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.62
CA2 P00918 3/20 0.62
CA7 P43166 2/20 0.62
CA9 Q16790 2/20 0.62
CA12 O43570 1/20 0.62
CA4 P22748 1/20 0.62
CA14 Q9ULX7 1/20 0.62
ALDH1A1 P00352 4/20 0.48
HTT P42858 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
MAPK1 P28482 1/20 0.48
TSHR P16473 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
TP53 P04637 1/20 0.44
ADRA2B P18089 1/20 0.44
PTGS1 P23219 1/20 0.44
POLB P06746 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
TLR2 O60603 1/20 0.44
ERN1 O75460 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9881101 0.87 ALDH1A1 (0.42) CA1CA2CA7CA9CA12
1,2-Dimethoxybenzene SCHEMBL27829075 0.82 CA1 (0.72) CA1CA2CA7CA9CA12
SCHEMBL14579654 0.80 IDO1 (0.53) CA1CA2CA7CA9CA12
SCHEMBL14579653 0.80 TLR2 (0.44) CA1CA2CA7CA9CA12
SCHEMBL2094874 0.80 NFE2L2 (0.47) CA1CA2CA7CA9CA12
SCHEMBL10640652 0.80 CA1 (0.68) CA1CA2CA7CA9CA12
1,2-Dimethoxybenzene SCHEMBL28252141 0.80 CA1 (0.68) CA1CA2CA7CA9CA12
1,2-Dimethoxybenzene SCHEMBL27945910 0.80 CA1 (0.68) CA1CA2CA7CA9CA12
SCHEMBL2094352 0.79 SMN1; SMN2 (0.48) CA1CA2CA7CA9CA12
1,2-Dimethoxybenzene SCHEMBL105872 0.79 CA1 (1.00) CA1CA2CA7CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 413 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119371309-A Indenoacetates method for synthesizing compound 南通大学 2025-01-28 CN claimed
US-20150119606-A1 Process for production of vanillin and vanillin derivatives RHODIA OPERATIONS (FR) 2015-04-30 US claimed
EP-2847156-A1 PROCESS FOR PRODUCTION OF VANILLIN AND VANILLIN DERIVATIVES Rhodia Operations (FR) 2015-03-18 EP claimed
WO-2013166642-A1 PROCESS FOR PRODUCTION OF VANILLIN AND VANILLIN DERIVATIVES RHODIA OPERATIONS (FR) 2013-11-14 WO claimed
WO-2013166946-A1 PROCESS FOR PRODUCTION OF VANILLIN AND VANILLIN DERIVATIVES RHODIA OPERATIONS (FR) 2013-11-14 WO claimed
EP-0934244-B1 METHOD FOR SELECTIVE PREPARATION OF A 2-HYDROXYBENZOIC ACID AND A 4-HYDROXYBENZALDEHYDE AND DERIVATIVES RHODIA CHIMIE SA (FR) 2004-12-15 EP claimed
US-20020168609-A1 DENTAL GLUE, GLUE INJECTOR, AND DEVICE FOR DETECTING INJECTED GLUE KUSANO KAZUNORI (JP) 2002-11-14 US claimed
EP-0946482-B1 METHOD FOR PREPARING A 4-HYDROXYBENZALDEHYDE AND DERIVATIVES RHODIA CHIMIE SA (FR) 2002-07-24 EP claimed
US-20020045148-A1 Paste formulation for dental use, a paste injector, and a system for detecting of paste filling KUSANO KAZUNORI (JP) 2002-04-18 US claimed
US-6245936-B1 MIXING PHENOLIC COMPOUNDS CARRYING FORMYL OR HYDROXYMETHYL GROUP, ONE IN 2 POSITION AND ONE IN 4 POSITION, SELECTIVELY OXIDIZING GROUP IN 2 POSITION TO CARBOXY GROUP, HYDROXYMETHYL GROUP IN 4 POSITION TO FORMYL GROUP, RECOVERING MIXTURE RHODIA CHIMIE (FR) 2001-06-12 US claimed
US-6184421-B1 SELECTIVE OXIDATION, TO A CARBOXY GROUP, OF THE GROUP IN THE 2 POSITION WITH RESPECT TO THE HYDROXYL GROUPS OF A MIXTURE OF PHENOLS HAVING FORMYL AND/OR HYDROXYMETHYL GROUPS IN POSITIONS 2 OR 4; PREPARING VANILLIN AND ETHYL VANILLIN RHODIA CHIMIE (FR) 2001-02-06 US claimed
EP-1027876-A1 DENTAL GLUE, GLUE INJECTOR, AND DEVICE FOR DETECTING INJECTED GLUE Kusano, Kazunori (JP) 2000-08-16 EP claimed
US-12252465-B2 Enol ether properfume FIRMENICH SA (CH) 2025-03-18 US disclosed
CN-119371309-A Indenoacetates method for synthesizing compound 南通大学 2025-01-28 CN disclosed
US-20240059640-A1 Enol Ether Properfume FIRMENICH SA (CH) 2024-02-22 US disclosed
CN-114292167-B Preparation method of vanillin 万华化学集团股份有限公司 2023-12-19 CN disclosed
EP-0180897-A2 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-14 EP disclosed
EP-0180188-A2 A composition for increasing the anti-cancer activity of an anti-cancer compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-07 EP disclosed
US-4351962-A Process for the preparation of hydroxy benzene carboxaldehydes RHONE POULENC INC. (US) 1982-09-28 US disclosed
US-4259350-A PROTECTING DEGRADABLE ORGANIC MATERIAL FROM FUNGAL OR INSECT ATTACK SANKYO COMPANY LIMITED (JP) 1981-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150119606-A1 Process for production of vanillin and vanillin derivatives UGDH, VARS1, SQLE CA1 2837/4885CA2 2411/4885CA7 2315/4885
US-12252465-B2 Enol ether properfume CYP2E1, ETFB, ECI1 CA1 3759/4885CA2 4316/4885CA7 2433/4885
US-20240059640-A1 Enol Ether Properfume CYP2E1, ETFB, ECI1 CA1 3759/4885CA2 4316/4885CA7 2433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.